Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$0.72 - $1.66 $1,784 - $4,115
2,479 Added 1.09%
229,924 $347,000
Q4 2023

Feb 08, 2024

BUY
$0.68 - $1.31 $154,662 - $297,952
227,445 New
227,445 $195,000
Q1 2021

May 12, 2021

SELL
$9.85 - $17.69 $509,806 - $915,581
-51,757 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$16.6 - $25.25 $658,173 - $1 Million
-39,649 Reduced 43.38%
51,757 $980,000
Q1 2020

May 14, 2020

BUY
$14.38 - $27.72 $1.31 Million - $2.53 Million
91,406 New
91,406 $1.76 Million
Q1 2019

May 15, 2019

SELL
$4.12 - $10.25 $415,794 - $1.03 Million
-100,921 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$8.2 - $16.95 $34,858 - $72,054
-4,251 Reduced 4.04%
100,921 $946,000
Q3 2018

Nov 13, 2018

SELL
$17.03 - $21.18 $2.17 Million - $2.7 Million
-127,541 Reduced 54.81%
105,172 $1.79 Million
Q2 2018

Aug 14, 2018

BUY
$12.0 - $19.88 $992,292 - $1.64 Million
82,691 Added 55.12%
232,713 $3.95 Million
Q1 2018

May 15, 2018

BUY
$9.92 - $17.25 $30,791 - $53,544
3,104 Added 2.11%
150,022 $2.01 Million
Q4 2017

Feb 14, 2018

BUY
$9.15 - $11.99 $627,790 - $822,645
68,611 Added 87.62%
146,918 $1.41 Million
Q3 2017

Nov 14, 2017

BUY
$8.15 - $11.16 $638,202 - $873,906
78,307
78,307 $860,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $49.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.